Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Laboratory Corp of America (LH)

Laboratory Corp of America (LH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Labcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health PR Newswire - Tue Aug 18, 6:00AM CDT

Collaboration will support leadership development, practice improvement and innovation across the nation's Community Health Centers

LH : 336.34 (+1.06%)
Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma PR Newswire - Mon Aug 10, 6:00AM CDT

BURLINGTON, N.C. , Aug. 10, 2026 /PRNewswire/ -- Labcorp  (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that the U.S. Food and Drug Administration...

LH : 336.34 (+1.06%)
LH
5 Revealing Analyst Questions From Labcorp’s Q2 Earnings Call StockStory - Thu Aug 6, 12:40AM CDT

5 Revealing Analyst Questions From Labcorp’s Q2 Earnings Call

LH : 336.34 (+1.06%)
Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer PR Newswire - Tue Aug 4, 6:00AM CDT

First FDA-approved IHC assay identifies patients who may be eligible for combination treatment with TRUQAP® (capivasertib)

LH : 336.34 (+1.06%)
LH
LH Q2 Deep Dive: Specialty Testing and Consumer Growth Drive Guidance Increase StockStory - Fri Jul 31, 12:42AM CDT

LH Q2 Deep Dive: Specialty Testing and Consumer Growth Drive Guidance Increase

LH : 336.34 (+1.06%)
LH
Labcorp (NYSE:LH) Reports Q2 CY2026 In Line With Expectations StockStory - Thu Jul 30, 7:21AM CDT

Labcorp (NYSE:LH) Reports Q2 CY2026 In Line With Expectations

LH : 336.34 (+1.06%)
Labcorp: Q2 Earnings Snapshot AP - Thu Jul 30, 5:58AM CDT

Labcorp: Q2 Earnings Snapshot

LH : 336.34 (+1.06%)
Labcorp Announces 2026 Second Quarter Results; Raises Full Year 2026 Guidance PR Newswire - Thu Jul 30, 5:50AM CDT

BURLINGTON, N.C. , July 30, 2026 /PRNewswire/ -- Labcorp Holdings Inc.  (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced results for the second...

LH : 336.34 (+1.06%)
Laboratory Corp: The Diagnostics Momentum That Brought a Guidance Raise Gets Its Second Test Barchart - Wed Jul 29, 4:14PM CDT

Barchart Research What to Expect from LH Earnings LH Generated July 29, 2026 Current Price $307.15 EPS Estimate $$4.79 Consensus Rating Strong Buy Average Move 4.18% Laboratory Corp: The Diagnostics Momentum...

LH : 336.34 (+1.06%)
LH
What To Expect From Labcorp’s (LH) Q2 Earnings StockStory - Tue Jul 28, 10:14PM CDT

What To Expect From Labcorp’s (LH) Q2 Earnings

LH : 336.34 (+1.06%)

Barchart Exclusives

Microsoft vs. Broadcom: One Has 85% Upside, But I'm Picking the Other Barchart - Fri Aug 21, 6:00PM CDT
Wall Street sees 85% upside in Broadcom versus 45% for Microsoft. But bigger upside doesn't always mean the better buy. Here's why I'm sticking with Microsoft as the smarter AI stock for 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.